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Surveillance of antimicrobial consumption
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for carbapenem resistance derived from a
retrospective analysis of an OXA-48 producing
K. pneumoniae outbreak
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Brannigan, K. Bamford, A.H. Holmes
Imperial College London and Imperial College
Healthcare NHS trust, London, United Kingdom
Background: This study describes the development of an auto-
mated surveillance system using antimicrobial consumption data
for the prediction of potential emergence of carbapenem-resistant
organisms. It was derived from a retrospective analysis of an inter-
vention to contain a prolonged OXA-48 producing K. pneumoniae
outbreak.
Methods & Materials: A time series analysis (May 2005-April
2013) was conducted around an intervention to contain an out-
break (Jan2008-April 2010)of anOXA-48-producingK. pneumoniae
in the renal unit of a West London teaching hospital. The inter-
vention focused on reinforcement of the renal antimicrobial policy
and the decrease of carbapenem usage, as part of the overall stew-
ardship strategy. Three mechanisms were promoted: awareness,
education and feedback. A multivariate ARIMA model was devel-
oped utilising meropenem consumption data (deﬁned daily dose
per 100 occupied bed-days; DDD/100OBD) as a predictor of the
incidence of OXA-48-producing organisms.
Results: Meropenem usage was increasing by
7.13DDD/100OBD/year (95%CI 3.46-10.80; p<0.001) from
6.30DDD/100OBD/year prior to the intervention but decreased
steadily for 4 years thereafter. The changes in slope of the time
series were -10.18DDD/100OBD/year (95% CI, -16.63-3.73). Anal-
ysis of consumption of other gram negative antimicrobials was
also undertaken and showed a signiﬁcant increase in amikacin
usage post-intervention from 0.56 to 4.07DDD/100OBD/year
(slope= +0.83; 95%CI, 0.13-1.53). The incidence of OXA-48-
producing organisms was signiﬁcantly increasing by 2.2 cases
per year pre-intervention, and decreased thereafter. Meropenem
usage at lag-1 year was highly correlated to the incidence of
OXA-48-producing organisms (r =0.74, pvalue =0.04) and was
included as a predictor within the ARIMA model for forecasting
the incidence of resistant isolates.
Conclusion: Our ﬁndings support an association between rein-
forcement of a speciﬁc antimicrobial policy and both meropenem
usage, and a decreasing incidence of OXA-48-producing K. pneu-
moniae. Meropenem usage at lag-1 year was found to be a good
predictor of the incidence of OXA-48-producing K. pneumoniae
in the ARIMA model, although we need to remain cautious about
the causality. This prediction model requires further development
but shows early signs of how close surveillance of antimicrobial
consumption can act as a warning indicator to anticipate potential
outbreaks of drug resistance organisms and should be considered
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Detection of antibiotic resistances of
Mycobacterium tuberculosis on DNA
microarrays
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Background: The infection with the bacterium Mycobacterium
tuberculosis is one of the biggest challenges of healthcare systems,
especially in South Africa or India. Associated with the extensive
use of antibiotics the spread of resistances is promoted. Due to this
a reliable and sensitive detection of infection and classiﬁcation of
resistances are needed.
Methods & Materials: DNA samples of South-African patients,
provided by the Stellenbosch University, are ampliﬁed via isother-
mal ampliﬁcation and hybridized on a DNA microarray. The array
consists of speciﬁc sequences of TB and genes involved in develop-
ing resistances against known drugs. First of all, genes leading to
resistances for ﬁrst line drugs lie in the focus. The immobilization of
the sequences is done with a non-contact spotter that requires low
amountofmaterial. Finally aﬂuorescent read-out is done for aqual-
itative statement of infection and resistances. Advantages of this
assay are e.g. a constant temperature for the isothermal ampliﬁca-
tion, avoiding heating steps and the sensitive ﬂuorescent detection
of the hybridized DNA.
Results: It is possible to detect low amounts of TB-DNA using
isothermal ampliﬁcation coupled with a DNA microarray. The
quantity of DNA in a typical saliva or blood sample is more than
sufﬁcient. Furthermoremajor genemutations responsible for resis-
tances against ﬁrst line drugs are detectable.
Conclusion: The presentedmethod depicts a novel way to diag-
nose TB infection and allows a prediction about resistances to the
most used antibiotics, i.e. all ﬁrst line drugs. As a perspective the
detection of further antibiotic resistances should be added to the
assay. The explained assay has the potential to give rise to new
diagnostic tools for detecting TB infection and drug resistances.
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